Underuse of β-Blockers following myocardial infarction [1] (multiple letters)

Journal of the American Medical Association

Volumn 285, Issue 8, 2001, Pages 1013-

  Budnitz, Daniel ^a   Neuman, W Richey ^a   Phillips, Kathryn A ^b   Shlipak, Michael G ^c   Coxson, Pam ^d   Goldman, Lee ^d   Heidenreich, Paul A ^e   Weinstein, Milton C ^f   Goldman, Paula A ^f  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c San Francisco Veterans Affairs ^*  (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e STANFORD UNIVERSITY   (United States)

^f HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Adrenergic beta antagonists; Beta blockers, adrenergic; Cost benefit analysis; Myocardial infarction

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

COST EFFECTIVENESS ANALYSIS; DRUG UTILIZATION; EVIDENCE BASED MEDICINE; HEART INFARCTION; HUMAN; LETTER; PATIENT COMPLIANCE; PRESCRIPTION; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR;

EID: 0035961586     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (0)